Sugi Predict

Sugi Predict / Compounds / SCHEMBL2552500

SCHEMBL2552500

SCHEMBL2552500

CCCCCCCCCCCCCCCCO[Si](CCC(C)N)(OCCCCCCCCCCCCCCCC)OCCCCCCCCCCCCCCCC

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ OPRM1 P35372 1/20 0.48
▸ TP53 P04637 1/20 0.40
▸ SPHK1 Q9NYA1 1/20 0.37
▸ DNM1 Q05193 1/20 0.36
▸ CA1 P00915 8/20 0.33
▸ CA2 P00918 8/20 0.33
▸ CA9 Q16790 7/20 0.33
▸ LPAR2 Q9HBW0 3/20 0.33
▸ LPAR3 Q9UBY5 3/20 0.33
▸ CA12 O43570 3/20 0.33
▸ CA7 P43166 3/20 0.33
▸ CA14 Q9ULX7 3/20 0.33
▸ CA3 P07451 2/20 0.33
▸ CA4 P22748 2/20 0.33
▸ CA6 P23280 2/20 0.33
▸ CA5A P35218 2/20 0.33
▸ CA5B Q9Y2D0 2/20 0.33
▸ HTT P42858 1/20 0.33
▸ SLC2A1 P11166 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2555162 1.00 OPRM1 (0.48) OPRM1TP53SPHK1DNM1CA1
SCHEMBL14482046 1.00 OPRM1 (0.48) OPRM1TP53SPHK1DNM1CA1
SCHEMBL14482722 1.00 OPRM1 (0.48) OPRM1TP53SPHK1DNM1CA1
SCHEMBL2552953 1.00 OPRM1 (0.48) OPRM1TP53SPHK1DNM1CA1
SCHEMBL2141411 0.92 OPRM1 (0.46) OPRM1TP53SPHK1SLC2A1
SCHEMBL2142853 0.84 OPRM1 (0.39) OPRM1TP53
SCHEMBL375590 0.81 LPAR2 (0.33) OPRM1SPHK1DNM1LPAR2LPAR3
SCHEMBL375792 0.81 LPAR2 (0.33) OPRM1SPHK1DNM1LPAR2LPAR3
SCHEMBL375624 0.81 LPAR2 (0.33) OPRM1SPHK1DNM1LPAR2LPAR3
SCHEMBL375704 0.81 LPAR2 (0.33) OPRM1SPHK1DNM1LPAR2LPAR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12570899-B2 Bright silver based quaternary nanostructures SHOEI CHEMICAL INC. (JP) 2026-03-10 — — US disclosed
US-20240263069-A1 BRIGHT SILVER BASED QUATERNARY NANOSTRUCTURES SHOEI CHEMICAL INC. (JP) 2024-08-08 — — US disclosed
US-11970646-B2 Bright silver based quaternary nanostructures SHOEI CHEMICAL INC. (JP) 2024-04-30 — — US disclosed
EP-3816247-B1 CURING MIXTURE EVONIK OPERATIONS GMBH (DE) 2022-12-07 — — EP disclosed
US-20220228057-A1 BRIGHT SILVER BASED QUATERNARY NANOSTRUCTURES NANOSYS, INC. (US) 2022-07-21 — — US disclosed
EP-3973033-A1 BRIGHT SILVER BASED QUATERNARY NANOSTRUCTURES Nanosys, Inc. (US) 2022-03-30 — — EP disclosed
US-11254819-B2 Curing agent mixture EVONIK OPERATIONS GMBH (DE) 2022-02-22 — — US disclosed
EP-2994495-B2 CROSSLINKING OF IPMS ADDUCTS AND AMINOSILANES EVONIK OPERATIONS GMBH (DE) 2021-09-22 — — EP disclosed
EP-3816247-A1 CURING MIXTURE Evonik Operations GmbH (DE) 2021-05-05 — — EP disclosed
US-20210122921-A1 Curing agent mixture EVONIK OPERATIONS GMBH (DE) 2021-04-29 — — US disclosed
EP-2994495-A1 CROSSLINKING OF IPMS ADDUCTS AND AMINOSILANES Evonik Industries AG (DE) 2016-03-16 — — EP disclosed
US-9266825-B2 Copolymers of isocyanatoalkyltrialkoxysilanes and urethanediols EVONIK DEGUSSA GMBH (DE) 2016-02-23 — — US disclosed
EP-2905296-B1 Copolymers made of isocyanatoalkyltrialkoxysilanes and urethane diols EVONIK DEGUSSA GMBH (DE) 2015-12-23 — — EP disclosed
US-20150225337-A1 COPOLYMERS OF ISOCYANATOALKYLTRIALKOXYSILANES AND URETHANEDIOLS EVONIK INDUSTRIES AG (DE) 2015-08-13 — — US disclosed
EP-2905296-A1 Copolymers made of isocyanatoalkyltrialkoxysilanes and urethane diols Evonik Degussa GmbH (DE) 2015-08-12 — — EP disclosed
EP-2552925-B1 PROCESS FOR THE PREPARATION OF SILICON CONTAINING AZODICARBAMIDES EVONIK DEGUSSA GMBH (DE) 2014-07-23 — — EP disclosed
US-8664370-B2 Process for preparing silicon-containing azodicarbamides EVONIK DEGUSSA GMBH (DE) 2014-03-04 — — US disclosed
EP-2552925-A1 PROCESS FOR PREPARING SILICON-CONTAINING AZODICARBAMIDES Evonik Degussa GmbH (DE) 2013-02-06 — — EP disclosed
US-20130012691-A1 Process for Preparing Silicon-Containing Azodicarbamides EVONIK OPERATIONS GMBH (DE) 2013-01-10 — — US disclosed
WO-2011120792-A1 PROCESS FOR PREPARING SILICON-CONTAINING AZODICARBAMIDES EVONIK DEGUSSA GMBH (DE) 2011-10-06 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12570899-B2 Bright silver based quaternary nanostructures LGALS3, ANXA3, ATXN2L OPRM1 2012/4885TP53 286/4885SPHK1 4284/4885
US-20130012691-A1 Process for Preparing Silicon-Containing Azodicarbamides C1R, CA9, CCNB3 OPRM1 3084/4885TP53 2770/4885SPHK1 3772/4885
US-20150225337-A1 COPOLYMERS OF ISOCYANATOALKYLTRIALKOXYSILANES AND URETHANEDIOLS ACMSD, OR10J3, CCND2 OPRM1 968/4885TP53 4658/4885SPHK1 1758/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.